[Trasylol in the treatment of hematomas of the knee joint in experimental and clinical studies].
D000293:Adolescent; D000328:Adult; D000368:Aged; D000818:Animals; D000893:Anti-Inflammatory Agents; D007611:Aprotinin / Q000008:administration & dosage*; D002648:Child; D005260:Female; D005343:Fibrinolytic Agents; D006395:Hemarthrosis / Q000188:drug therapy*; D006406:Hematoma / Q000188:drug therapy*; D006801:Humans; D007270:Injections, Intra-Articular; D007719:Knee Joint / Q000187:drug effects*; D008297:Male; D008875:Middle Aged; D011480:Protease Inhibitors / Q000008:administration & dosage*; D011817:Rabbits
D000893:Anti-Inflammatory Agents; D005343:Fibrinolytic Agents; D011480:Protease Inhibitors; D007611:Aprotinin
Trasylol w leczeniu krwiaków stawu kolanowego w doświadczeniu i w klinice.